Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy.

6 The appearance of molecular-targeted therapy involving VEGFR-TKI has facilitated the switch to effective drugs in the early stage even in patients who initially received cytokines, and this finding may be significant.

also in 13,097 other papers